[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2025 Human Growth Hormone Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

January 2018 | 120 pages | ID: 211F4E7A298EN
QYResearch

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This report studies the Human Growth Hormone Drugs market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Human Growth Hormone Drugs market by product type and application/end industries.

The global Human Growth Hormone Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Growth Hormone Drugs.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Human Growth Hormone Drugs in these regions, from 2013 to 2025 (forecast), covering
  • United States
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa
The major players in global and United States market, including
  • Eli Lilly and Company (US)
  • Ferring Holding SA (Switzerland)
  • Genentech, Inc. (US)
  • GeneScience Pharmaceuticals Co., Ltd. (China)
  • Merck KgaA (Germany)
  • Novo Nordisk A/S (Denmark)
  • Pfizer, Inc. (US)
  • Sandoz International GmbH (Germany)
On the basis of product, the market is primarily split into
  • Norditropin
  • Genotropin
  • Humatrope
  • Saizen
  • Omnitrope - the Somatropin Biosimilar
  • Somatropin Biopartners
On the basis on the end users/application, this report covers
  • Prader-Willi Syndrome
  • Turner Syndrome
  • Short Stature Homeobox Gene
  • Small for Gestational Age
  • Chronic Renal Insufficiency
  • Short Bowel Syndrome
2018-2025 HUMAN GROWTH HORMONE DRUGS REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 HUMAN GROWTH HORMONE DRUGS MARKET OVERVIEW

2.1 Human Growth Hormone Drugs Product Overview
2.2 Human Growth Hormone Drugs Market Segment by Type
  2.2.1 Norditropin
  2.2.2 Genotropin
  2.2.3 Humatrope
  2.2.4 Saizen
  2.2.5 Omnitrope - the Somatropin Biosimilar
  2.2.6 Somatropin Biopartners
2.3 Global Human Growth Hormone Drugs Product Segment by Type
  2.3.1 Global Human Growth Hormone Drugs Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Human Growth Hormone Drugs Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Human Growth Hormone Drugs Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Human Growth Hormone Drugs Price (USD/Pcs) by Type (2013-2018)
2.4 United States Human Growth Hormone Drugs Product Segment by Type
  2.4.1 United States Human Growth Hormone Drugs Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Human Growth Hormone Drugs Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Human Growth Hormone Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Human Growth Hormone Drugs Price (USD/Pcs) by Type (2013-2018)

3 HUMAN GROWTH HORMONE DRUGS APPLICATION/END USERS

3.1 Human Growth Hormone Drugs Segment by Application/End Users
  3.1.1 Prader-Willi Syndrome
  3.1.2 Turner Syndrome
  3.1.3 Short Stature Homeobox Gene
  3.1.4 Small for Gestational Age
  3.1.5 Chronic Renal Insufficiency
  3.1.6 Short Bowel Syndrome
3.2 Global Human Growth Hormone Drugs Product Segment by Application
  3.2.1 Global Human Growth Hormone Drugs Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Human Growth Hormone Drugs Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Human Growth Hormone Drugs Product Segment by Application
  3.3.1 United States Human Growth Hormone Drugs Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Human Growth Hormone Drugs Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 HUMAN GROWTH HORMONE DRUGS MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Human Growth Hormone Drugs Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Human Growth Hormone Drugs Sales and Revenue by Regions
  4.2.1 Global Human Growth Hormone Drugs Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Human Growth Hormone Drugs Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL HUMAN GROWTH HORMONE DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Human Growth Hormone Drugs Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Human Growth Hormone Drugs Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Human Growth Hormone Drugs Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Human Growth Hormone Drugs Manufacturing Base Distribution, Sales Area, Product Types
5.5 Human Growth Hormone Drugs Market Competitive Situation and Trends
  5.5.1 Human Growth Hormone Drugs Market Concentration Rate
  5.5.2 Global Human Growth Hormone Drugs Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES HUMAN GROWTH HORMONE DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Human Growth Hormone Drugs Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Human Growth Hormone Drugs Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Human Growth Hormone Drugs Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Human Growth Hormone Drugs Market Share (%) of Top 3 and Top 5 Players

7 HUMAN GROWTH HORMONE DRUGS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Eli Lilly and Company (US)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Ferring Holding SA (Switzerland)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Genentech, Inc. (US)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 GeneScience Pharmaceuticals Co., Ltd. (China)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Merck KgaA (Germany)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Novo Nordisk A/S (Denmark)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Pfizer, Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Sandoz International GmbH (Germany)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Human Growth Hormone Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview

8 HUMAN GROWTH HORMONE DRUGS MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Human Growth Hormone Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Human Growth Hormone Drugs Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL HUMAN GROWTH HORMONE DRUGS MARKET FORECAST

10.1 Global Human Growth Hormone Drugs Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.1 Global Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Human Growth Hormone Drugs Market Forecast
  10.2.1 United States Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Human Growth Hormone Drugs Forecast by Regions
  10.3.1 North America Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Human Growth Hormone Drugs Forecast by Type
  10.4.1 Global Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Human Growth Hormone Drugs Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Human Growth Hormone Drugs Forecast by Application
  10.5.1 Global Human Growth Hormone Drugs Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Human Growth Hormone Drugs Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Human Growth Hormone Drugs Product Picture
Figure Global Human Growth Hormone Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Human Growth Hormone Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Norditropin
Table Major Players of Norditropin
Figure Global Norditropin Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Genotropin
Table Major Players of Genotropin
Figure Global Genotropin Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Humatrope
Table Major Players of Humatrope
Figure Global Humatrope Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Saizen
Table Major Players of Saizen
Figure Global Saizen Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Omnitrope - the Somatropin Biosimilar
Table Major Players of Omnitrope - the Somatropin Biosimilar
Figure Global Omnitrope - the Somatropin Biosimilar Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Somatropin Biopartners
Table Major Players of Somatropin Biopartners
Figure Global Somatropin Biopartners Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Human Growth Hormone Drugs Sales (K Pcs) by Type (2013-2018)
Table Global Human Growth Hormone Drugs Sales Share (%) by Type (2013-2018)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) by Type (2013-2018)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) by Type in 2017
Table Global Human Growth Hormone Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Human Growth Hormone Drugs Revenue Share (%) by Type (2013-2018)
Figure Global Human Growth Hormone Drugs Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Human Growth Hormone Drugs Revenue Market Share (%) by Type
Table Global Human Growth Hormone Drugs Price (USD/Pcs) by Type (2013-2018)
Table United States Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Human Growth Hormone Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Human Growth Hormone Drugs Sales Share (%) by Type (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share (%) by Type (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share (%) by Type in 2017
Table United States Human Growth Hormone Drugs Revenue (Million USD) by Type (2013-2018)
Table United States Human Growth Hormone Drugs Revenue Share (%) by Type (2013-2018)
Figure United States Human Growth Hormone Drugs Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Human Growth Hormone Drugs Revenue Market Share (%) by Type
Table United States Human Growth Hormone Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Prader-Willi Syndrome Examples
Figure Turner Syndrome Examples
Figure Short Stature Homeobox Gene Examples
Figure Small for Gestational Age Examples
Figure Chronic Renal Insufficiency Examples
Figure Short Bowel Syndrome Examples
Table Global Human Growth Hormone Drugs Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Human Growth Hormone Drugs Sales (K Pcs) by Application (2013-2018)
Table Global Human Growth Hormone Drugs Sales Share (%) by Application (2013-2018)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) by Application (2013-2018)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) by Application in 2017
Table United States Human Growth Hormone Drugs Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Human Growth Hormone Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Human Growth Hormone Drugs Sales Share (%) by Application (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share (%) by Application (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share (%) by Application in 2017
Table Global Human Growth Hormone Drugs Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Human Growth Hormone Drugs Sales (K Pcs) by Regions (2013-2018)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) by Regions (2013-2018)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Human Growth Hormone Drugs Sales Market Share (%) by Regions
Figure 2017 United States Human Growth Hormone Drugs Sales Market Share (%) in Global Market
Table Global Human Growth Hormone Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Human Growth Hormone Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure Global Human Growth Hormone Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Human Growth Hormone Drugs Revenue Market Share (%) by Regions
Figure 2017 United States Human Growth Hormone Drugs Revenue Market Share (%) in Global Market
Table Global Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Human Growth Hormone Drugs Sales (K Pcs) of Key Players (2013-2018)
Table Global Human Growth Hormone Drugs Sales Share (%) by Players (2013-2018)
Figure 2017 Global Human Growth Hormone Drugs Sales Share (%) by Players
Figure 2018 Global Human Growth Hormone Drugs Sales Share (%) by Players
Table Global Human Growth Hormone Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Human Growth Hormone Drugs Revenue Share (%) by Players (2013-2018)
Table 2017 Global Human Growth Hormone Drugs Revenue Share (%) by Players
Table 2017 Global Human Growth Hormone Drugs Revenue Share (%) by Players
Table Global Market Human Growth Hormone Drugs Average Price (USD/Pcs) by Players (2013-2018)
Table Global Human Growth Hormone Drugs Top Players Manufacturing Base Distribution and Sales Area
Table Global Human Growth Hormone Drugs Top Players Product Category
Figure Global Human Growth Hormone Drugs Market Share (%) of Top 3 Players
Figure Global Human Growth Hormone Drugs Market Share (%) of Top 5 Players
Table United States Human Growth Hormone Drugs Sales (K Pcs) by Players (2013-2018)
Table United States Human Growth Hormone Drugs Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Human Growth Hormone Drugs Sales Share (%) by Players
Figure 2018 United States Human Growth Hormone Drugs Sales Share (%) by Players
Table United States Human Growth Hormone Drugs Revenue (Million USD) by Players (2013-2018)
Table United States Human Growth Hormone Drugs Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Human Growth Hormone Drugs Revenue Share (%) by Players
Table 2017 United States Human Growth Hormone Drugs Revenue Share (%) by Players
Table United States Market Human Growth Hormone Drugs Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Human Growth Hormone Drugs Market Share (%) of Top 3 Players
Figure United States Human Growth Hormone Drugs Market Share (%) of Top 5 Players
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Ferring Holding SA (Switzerland) Basic Information List
Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Genentech, Inc. (US) Basic Information List
Table Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information List
Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Merck KgaA (Germany) Basic Information List
Table Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Novo Nordisk A/S (Denmark) Basic Information List
Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Sandoz International GmbH (Germany) Basic Information List
Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales Global Market Share (%)(2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Growth Hormone Drugs
Figure Human Growth Hormone Drugs Industrial Chain Analysis
Table Major Buyers of Human Growth Hormone Drugs
Table Distributors/Traders List
Figure Global Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Human Growth Hormone DrugsHuman Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Human Growth Hormone Drugs Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Human Growth Hormone Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Human Growth Hormone Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Human Growth Hormone Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Human Growth Hormone Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Human Growth Hormone Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Human Growth Hormone Drugs Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Human Growth Hormone Drugs Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Human Growth Hormone Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Human Growth Hormone Drugs Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Human Growth Hormone Drugs Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Human Growth Hormone Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Human Growth Hormone Drugs Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Human Growth Hormone Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Human Growth Hormone Drugs Sales Forecast by Application (2018-2025)
Table United States Human Growth Hormone Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Forecast by Application (2018-2025)


More Publications